Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

2.92%

Category Returns

3.41%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) 0.19 2.64 2.92 7.81 16.33 25.75 14.16 22.41 20.60
Equity - Sectoral Fund - Pharma & Health Care 0.05 2.50 3.41 10.58 8.27 28.40 20.22 27.89 17.47

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    518.9092

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032

  • Phone

    (040) 23312454 23320751 23320752

  • Fax

    (040) 23311968

  • Email

    customercare@karvy.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 98.58
Others : 1.42

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 104956.51 12.57
Divi's Laboratories Limited 79265.18 9.49
Lupin Limited 48629.09 5.82
Cipla Limited 46902.4 5.62
Dr. Reddy's Laboratories Limited 45821.07 5.49
Apollo Hospitals Enterprise Limited 44640.34 5.34
MedPlus Health Services Limited 35054 4.2
GlaxoSmithKline Pharmaceuticals Limited 31129.91 3.73
Vijaya Diagnostic Centre Limited 27078.25 3.24
Narayana Hrudayalaya Limited 24535.73 2.94
Gland Pharma Limited 24295.29 2.91
Ajanta Pharma Limited 24086.68 2.88
Abbott India Limited 23961.08 2.87
Dr. Lal Path Labs Limited 19760.11 2.37
Aurobindo Pharma Limited 19542.79 2.34
Mankind Pharma Limited 18692.73 2.24
Zydus Lifesciences Limited 18605.88 2.23
Thyrocare Technologies Limited 18527.17 2.22
Pfizer Limited 17864.27 2.14
JB Chemicals & Pharmaceuticals Limited 16757.12 2.01
Alkem Laboratories Limited 16502.72 1.98
Sanofi India Limited 14259.59 1.71
Triparty Repo 12729.64 1.52
Sai Life Sciences Limited 11696.23 1.4
Sanofi Consumer Healthcare India Limited 11256.84 1.35
IPCA Laboratories Limited 11190.55 1.34
Suraksha Diagnostic Limited 10177.64 1.22
Torrent Pharmaceuticals Limited 9630.9 1.15
Fortis Healthcare Limited 7796.77 0.93
Biocon Limited 7671.56 0.92
Syngene International Limited 7272.36 0.87
Emcure Pharmaceuticals Limited 6254.15 0.75
AstraZeneca Pharma India Limited 5108.3 0.61
Akums Drugs and Pharmaceuticals Limited 4763.86 0.57
Indoco Remedies Limited 4599.79 0.55
Orchid Pharma Limited 3098.02 0.37
Concord Biotech Limited 1953.74 0.23
Cash Margin - CCIL 6.21 0
Net Current Assets -858.03 -0.1

Sectors - Holding Percentage

Sector hold percentage
Healthcare 97.71%
Miscellaneous 1.52%
Business Services 0.87%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 3.77 5.71 -0.75 28.33 0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 102.69 4.26 6.22 -1.07 28.28 0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 2.21 8.81 -1.2 22.29 29.89
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 3.43 6.64 -2.16 21.54 26.9
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 7.7 3.43 5.06 -0.85 20.96 29.3
LIC MF Healthcare Fund-Regular Plan-Growth 51.46 3.25 2.72 -4.14 17.55 21.69
Mirae Asset Healthcare Fund -Regular Growth 1583.14 3.37 4.47 -3.01 17.21 23.88
DSP Healthcare Fund - Regular Plan - Growth 1243.08 3.09 4.31 -5.84 16.86 26.47
Nippon India Pharma Fund-Growth Plan-Growth 4510.77 2.92 7.81 -1.15 16.33 25.75
Kotak Healthcare Fund - Regular Plan - Growth Option 214.38 3.71 5.42 -5.54 16.23 0

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 63006.73 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 61973.76 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 61646.36 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 61027.03 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 60999.55 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 60372.55 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 58028.59 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 57009.7 4.53 15.67 -0.04 2.15 30.46
Nippon India Small Cap Fund - Growth Plan - Growth Option 56468.75 4.53 15.67 -0.04 2.15 30.46